TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Tissue carbon dioxide level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VTE events within 28 days after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: 30-second chair stand test (30CST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexuality of the female of the couple
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sexuality of the male of the couple
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ejaculation of the male of the couple
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resectable rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Differences in Diastolic Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Differences in Systolic Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correction rates using CaP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correction rates using PMMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multiple-Choice Questionnaire (MCQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognition - Zambian Mini-Mental Status Examination (zMMSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognition - International HIV Dementia Scale (I-HDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mental Health - The Alcohol Use Disorders Identification Test (AUDIT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: faecal abundance of Bifidobacterium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission from Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Telogen hair proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Positive and Negative Relationship Quality (PN-RQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ischemic stroke recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Successful application of CURATE.AI profile
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: area under the curve (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak concentration (Coax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ten-year Implant survival
Endpoint domain: Mortality/survival
Primary endpoint: Ten-year prosthesis survival
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of children breastfed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Prevalence of children formula-fed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Mean over 3 days of macronutrient intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline to Week 3 Psychomotor Function Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline to Week 3 Attention Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline to Week 3 Overall Well-Being Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to infection onset prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Assessment of airways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hypoxia in the newborn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Anemia in the newborn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of hypoxic-ischemic encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Turnaround time (TAT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 9-month Quality of Life (QOL) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Nitroglycerin Luminal Dilation Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hand manual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sentinel Node detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients reaching SDAI <= 3.3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reaching DAS28 LDA state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported outcomes (function, health-related quality of life, fatigue)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Percentage of participants with complete remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with complete remission with incomplete marrow recovery (CRi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impressions - Severity scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Niacin reaction test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of snoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and Number of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in Clinical Laboratory Parameters (Hematology): White Blood Cell Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in visual analogue scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antitumor activity of MEDI5752
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Consciousness recovery of patients with pDoC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knowledge Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Confidence Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Impact Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Upper extremity angle measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time zero extrapolated to infinite time (AUC[0-infinity])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with a wound complication after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor uptake of contrast agent (Peak Intensity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to peak (TP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-time conscious movement processing propensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of patients having had a PJI or BJI treated by daptomycin
Endpoint domain: Mortality/survival
Primary endpoint: rate of patients having had an adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Overactive Bladder bother score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant study retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Home practice completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative IOL rotation degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Agreement Measured with Likert Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Screening adherence with Community Health Worker
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants who engaged in a referred screening service
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: whole-mouth periodontal pocket depth improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in percentage of deep periodontal pocket
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Outcome Score-Extended
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: post-operative AKI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proof of cure
Endpoint domain: Mortality/survival
Primary endpoint: Hammersmith Neonatal Neurological Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Parental Stress Scale: Neonatal Intensive Care Unit
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Abnormal clinical laboratory values
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in children's anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in children's depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in children's severity of psychopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Donor site pain perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Secondary bleeding time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Goal Attainment Scaling Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Common Concussive Cognitive Complaints (C4) Inventory Change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neurobehavioral Symptom Inventory (NSI) Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Key Behaviors Change Inventory (KBCI)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Adverse effects associated with the therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Worsening of diabetic cardiomyopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial perfusion and cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants in Whom the Biopsy Approach Detected the Presence of Prostate Cancer (PCa) of Any Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Length of Cancerous Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Locoregional failure-free survival (LRFFS)
Endpoint domain: Mortality/survival
Primary endpoint: COVID-19 death
Endpoint domain: Mortality/survival
Primary endpoint: Development of cardiogenic shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alcohol use frequency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Alcohol use quantity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neurochemical concentration levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arm Research Action Test (ARAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time Zero to Time of the Last Quantifiable Concentration (AUC(0-T))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time Zero Extrapolated to Infinite Time (AUC(INF))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gastrointestinal peptides and lipid hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serum bone remodelling markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rebound / Relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter-Associated Urinary Tract Infection (CAUTI) Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Free radical concentration in seminal plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free radical concentration in serum using Diamond magnetometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Malondialdehyde levels in serum using the TBARS assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite complete remission rate (CCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in peri-implant marginal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percent change in pain questionnaires (VAS and GUPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTau264
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in swallowing function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palmitate release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Brief Pain Inventory Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Veteran's RAND 36 Item Health Survey (VR-36) Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PROMIS Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in total lesioned skin surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Microbial signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants who experience local solicited adverse events (AEs) in Part A
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants who experience systemic solicited AEs in Part A
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants who experience unsolicited severe adverse events (SAEs) Part A
Endpoint domain: Adverse events/effects
Primary endpoint: Time of the first rescue analgesic dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Atalante exoskeleton
Endpoint domain: Adverse events/effects
Primary endpoint: Overall efficacy response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear fluorescein break-up time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of recurrence
Endpoint domain: Mortality/survival
Primary endpoint: T cell populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stigma Scale for Relatives of Patients with Schizophrenia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Digital health literacy (focus: digital information retrieval skills)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Digital health literacy (focus: digital interactive skills)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acceptance towards Digital Navigators
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Added Sugar Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: C2-C7 COBB ANGLE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C2-C7 POSTERIOR TANJANT ANGLE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C2-C7 CERVICAL VERTEBRAL ALIGNMENT (CVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in haemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Stigma score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral manifestations of HIV stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of serum triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants with Immune Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postoperative pain measured by FLACC pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Thickness assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tendon Thickness assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Strength assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood glucose measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: titer of neutralizing antibody after COVID-19 vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: improvement in symptoms of PCOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic precision of uterine tumours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum Valproic acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of overt aGVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Immediate information recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Delayed information recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vitamin D3 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of respiratory failure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of movement and/or rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of MTS - measured facial perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gleason Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical Jump Test (VJT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Universal Goniometric Measurement (UGM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of TNS reported
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women randomised to treatment groups
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of women that take up the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of women withdrawn or lost to follow up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: IGM recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional Ventilation distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 24 hour urine free cortisol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in adenoma size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: oocyte's mtDNA expression in Cumulus Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: oocyte quality through levels of protein BMP-15
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: oocyte quality through levels of protein HSPG2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Bone level change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinesophobia levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acylglycine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acylcarnitine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glutathione concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Max pain experienced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average pain experienced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes